As of November 6, 2026, Danaher Corp /De/ has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from August 3, 2026 to October 13, 2026, naming 2 appointments and 1 departure. The latest filing names Daniel L. Comas, appointed (Form 8-K, October 13, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Danaher Corp /De/? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Danaher Corp /De/ reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-08-03 to 2026-10-13. They name 3 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Danaher Corp /De/ files it.
Also on the record for Danaher Corp /De/
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G, by FMR LLC | 5.6% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 6.69% of the class | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 8.63% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Danaher Corp /De/ now and the warning signs.
Free to see. No signup.
Keep reading
More on Danaher Corp /De/ and the records around it.
Danaher Corp /De/ elsewhere on the record
Companies that share a holder
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Danaher Corp /De/
Get an email when Danaher Corp /De/ files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Danaher Corp /De/?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Danaher Corp /De/: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Danaher Corp /De/ covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-13 | In | 8-K, 2026-10-13 | |||
| 2026-10-13 | Out | Director | 8-K, 2026-10-13 | ||
| 2026-08-03 | In | 8-K, 2026-08-03 |
Who leads Danaher Corp /De/, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Alan G. Spoon, departure reported (filed 2026-10-13). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Danaher Corp /De/: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Danaher Corp /De/, with the record behind each one.
Find candidates like Director at Danaher Corp /De/Every change, in the filing's words
Appointed: Daniel L. Comas
Director Appointments On October 9, 2026, the Board of Directors (the "Board") of Danaher Corporation (the "Company" or "Danaher") increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.
Departing: Alan G. Spoon, Director
Except as described above, there are no other transactions involving Mr. Comas or Dr. Hershberg that the Company is required to report pursuant to Item 404(a) of Regulation S-K. Director Retirements On October 9, Alan G. Spoon notified the Company of his decision to retire as a member of the Board, effective as of the Company's 2027 annual meeting of shareholders (the "2027 Annual Meeting").
- Each of Mr. Comas and Dr. Hershberg will serve until the Company's next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.
- Dr. Hershberg has also been appointed to serve as a member of the Science and Technology Committee of the Board.
- Daniel L. Comas, age 62, joined the Company in 1991 and served as Executive Vice President from April 2005 through December 2020, including as Chief Financial Officer from April 2005 through December 2018.
- During his tenure, Mr. Comas held various roles with responsibility for corporate development, treasury, finance and risk management.
- From January 2021 through March 2024, Mr. Comas was employed by the Company in a non-executive capacity as a senior advisor, and following his retirement from the Company in March 2024 through September 2026 he served as a consultant to the Company (upon the terms described below).
- He has also served as a director of Fortive Corporation since March 2021 and Veralto Corporation since September 2023.
- Robert M. Hershberg, M.D., Ph.D., age 63, served as President, Chief Executive Officer and Chairman of HilleVax, Inc. from March 2020 through September 2025.
- Before joining HilleVax, he held senior executive roles at Celgene Corporation, including Executive Vice President and Chief Scientific Officer.
Appointed: Rainer M. Blair
Transition Letter Agreement with Mr. Blair To document Mr. Blair's transition arrangements, on August 3, 2026, the Company entered into a letter agreement with Mr. Blair (the "Blair Transition Letter") pursuant to which, effective as of the Effective Date, Mr. Blair will assume the position of Senior Advisor and will remain a non-officer employee of the Company through December 31, 2026 (the "Employment Separation Date") and, following the Advisory Period, serve as a non-employee consultant through March 31, 2027.
- Appointment of Julie Sawyer Montgomery as President and Chief Executive Officer On August 3, 2026, Danaher Corporation (the "Company" or "Danaher") announced that, effective as of October 1, 2026 (the "Effective Date"), the Board of Directors of the Company (the "Board") has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the "CEO").
- The Board also appointed Ms. Sawyer Montgomery to the Board and to each of the Executive, Finance and Science & Technology Committees of the Board, in each case effective as of the Effective Date.
- Biographical Information Since joining the Company in 2017, Ms. Sawyer Montgomery, age 54, has served in a series of progressively more responsible general management positions (and as a Danaher officer since 2024), including as President of Danaher's Beckman Coulter Diagnostics subsidiary from January 2020 to December 2022, as Vice President - Group Executive of Danaher's Diagnostics subsidiary from January 2023 to June 2024 and as Executive Vice President since July 2024.
- Offer Letter with Ms. Sawyer Montgomery On August 3, 2026, the Company entered into an offer letter with Ms. Sawyer Montgomery (the "Offer Letter") establishing her compensation as President and CEO.
Tools for this story
Each opens in a new tab, filled in for Danaher Corp /De/. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.